돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 76958생성일: 2026년 10월 26일

1,1'-Carbonyldiimidazole → 5-(4-(N-trifluoroacetyl-2-aminoethoxy)but-2-yn-1-yl)-2',3' dideoxyuridine-5'-triphosphate

https://huagongshe.com/reaction/76958

반응식

참여 물질

역할이름HCID투입량
반응물1,1'-CarbonyldiimidazoleHCID 68263—
반응물Tetrabutylammonium pyrophosphateHCID 22385563—
반응물5-(4-(N-trifluoroacetyl-2-aminoethoxy)but-2-yn-1-yl)-2',3'-dideoxyuridine-5'-monophosphateHCID 60025111—
생성물5-(4-(N-trifluoroacetyl-2-aminoethoxy)but-2-yn-1-yl)-2',3' dideoxyuridine-5'-triphosphateHCID 86599849—

반응 단계

Without being limiting in any way, monophosphate (6) can optionally be formed by treatment of 5-(4-(N-trifluoroacetyl-2-aminoethoxy)but-2-yn-1-yl)-2′,3′ dideoxyuridine (5) with, for example, POCl3. 5-(4-(N-trifluoroacetyl-2-aminoethoxy)but-2-yn-1-yl)-2′,3′-dideoxyuridine-5′-monophosphate (6) can then optionally be treated with, for example, carbonyldiimidazole (CDI) followed by tetrabutylammonium pyrophosphate (TBAPP) under appropriate conditions to form 5-(4-(N-trifluoroacetyl-2-aminoethoxy)but-2-yn-1-yl)-2′,3′ dideoxyuridine-5′-triphosphate (7). It will be recognized by one of skill in the art that conversion of 5-(4-(N-trifluoroacetyl-2-aminoethoxy)but-2-yn-1-yl)-2′,3′ dideoxyuridine (5) to triphosphate (7) can be accomplished by any method known in the art.

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US08835625B2
출처 데이터셋uspto-grants-2014_09
ORD IDord-0c16297d1b474a4b970b072acda2c592
출처 메모uspto-grants-2014_09